Interim clinical trials suggest Covid-19 oral pill can halve risk of hospitalisation
A U.S. drug-maker Merck has announced the results of its experimental drug and the results are impressive.
A U.S. drug-maker Merck has announced the results of its experimental drug and the results are impressive.